| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000015768 |
| Receipt No. | R000018160 |
| Scientific Title | A cohort study of pediatric chronic kidney disease |
| Date of disclosure of the study information | 2014/11/28 |
| Last modified on | 2020/06/05 (Ver. 6) |
| Basic information | ||
| Public title | A cohort study of pediatric chronic kidney disease | |
| Acronym | P-CKD cohort study | |
| Scientific Title | A cohort study of pediatric chronic kidney disease | |
| Scientific Title:Acronym | P-CKD cohort study | |
| Region |
|
|
| Condition | ||
| Condition | Pediatric pre-dialysis chronic kidney disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | - To elucidate the natural history, complications, and prognosis of pediatric chronic kidney disease (CKD)
- To investigate the mechanism, management (including surgery), and prognosis of complications associated with congenital anomalies of kidney and urinary tract (CAKUT), which is the major cause of pediatric CKD |
| Basic objectives2 | Others |
| Basic objectives -Others | - To collect data on perinatal cortical necrosis |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Initiation of dialysis or renal transplantation (with the date and details of procedure) |
| Key secondary outcomes | Annual examinations:
1) Physical examination with the measurement date: height, weight, and blood pressure 2) Use of growth hormones 3) Blood test with the measurement date: Hb, Ht, serum Cr (SCr), Alb, BUN, Na, K, Ca, IP, ferritin, Fe, TIBC, intact PTH, cystatin C, and blood gas 4) Urinalysis with the measurement date: protein (qualitative and semiquantitative) and Cr 5) Use of milk for CKD patient 6) Death: the date, cause, and detailed course of death Examinations for CAKUT (including neurogenic bladder) 1) Complicating congenital urinary tract abnormality 2) Obstructive uropathy (e.g. posterior urethral valves, ureteral cancer, hydronephrosis, hydroureter) 3) Bladder dysfunctions (including neurogenic bladder) 4) Date and process of detection (with height and SCr), date of surgery (with height and SCr), management procedure, and outcome of above 2) and 3) 5) Anal atresia Investigation of (perinatal) cortical necrosis 1) Characteristics of the mother: age, underlying disease, and prenatal medication 2) health status at birth: gestational age (weeks), parity , fetal complications, and Apgar score 3) Resuscitation 4) Complications within 14 days after birth including: pneumothorax, patent ductus arteriosus, pulmonary hypertension, gastrointestinal perforation, cerebral hemorrhage, subgaleal hematoma, periventricular leukomalacia, sepsis, oliguria, anuria 5) Interventions after birth (excluding medical therapy): ventilator, umbilical catheter, cardiac surgery, acute blood purification therapy, exchange transfusion 6) Medical therapy after birth 7) Minimum blood pressure value during neonatal period 8) Serum BUN and Cr: peak level within 14 days after birth |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Predialysis patients with CKD in stage 3 or worse, based on the diagnostic criteria for CKD | |||
| Key exclusion criteria | History of dialysis or kidney transplantation | |||
| Target sample size | 400 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kitasato University School of Medicine
|
||||||
| Division name | Department of Pediatrics | ||||||
| Zip code | 252-0374 | ||||||
| Address | 1-15-1, Kitasato, Minami-ku, Sagamihara | ||||||
| TEL | 042-778-8111 | ||||||
| kenzo@ii.e-mansion.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Faculty of Medicine, Toho University | ||||||
| Division name | Department of Nephrology | ||||||
| Zip code | 143-8541 | ||||||
| Address | 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541 , Japan | ||||||
| TEL | 03-3762-4151 | ||||||
| Homepage URL | |||||||
| yuhamasaki@med.toho-u.ac.jp | |||||||
| Sponsor | |
| Institute | Japanese Pediatric CKD Study Group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics committee, Kitasato University Hospital |
| Address | 1-15-1, Kitasato, Minami-ku, Sagamihara |
| Tel | 042-778-8111 |
| rinrib@med.kitasato-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | The cohort of pediatric CKD patients was established in 2010.
We have previously revealed the frequency, severity and clinical state , and short-term prognosis. The study will be continued to |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018160 |